Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
37.48
-5.44 (-12.67%)
At close: May 02, 2025, 3:59 PM
37.73
0.65%
After-hours: May 02, 2025, 05:57 PM EDT

Cytokinetics Revenue

Cytokinetics reported an annual revenue of $18.47M, reflecting a 145.34% growth. For the quarter ending December 31, 2024, Cytokinetics generated $16.93M in revenue.
Revenue (ttm)
$18.47M
Revenue Growth
145.34%
Price / Sales Ratio
285.13
Revenue / Employee
$37.1K
Employees
498
Market Cap
4.47B

Revenue Chart

Created with Highcharts 11.4.355.83M55.83M70.43M70.43M94.59M94.59M7.53M7.53M18.47M18.47M20202021202220232024050M100M

Cytokinetics Revenue - Annual

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 18.47M +145.34%
Dec 31, 2023 7.53M -92.04%
Dec 31, 2022 94.59M +34.30%
Dec 31, 2021 70.43M +26.15%
Dec 31, 2020 55.83M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.